Instrument Inactif

Communiqués RLS Global AB (publ) Nasdaq Stockholm

Actions

SE0005190725

Produits pharmaceutiques

Communiqués

20/11/23	RLS Global ansöker om konkurs	AQ
09/11/23	RLS Global initiates strategic review process aiming to commercialize ChloraSolv	AQ
09/11/23	RLS Global and Convatec have agreed to terminate collaboration agreement	AQ
06/09/23	First patient included in new clinical investigation on pressure ulcers	AQ
01/09/23	ChloraSolv recommended for UK CA certification required for UK market after Brexit	AQ
28/08/23	RLS Global Q2 2023 - Uncertain future	AQ
25/08/23	RLS GLOBAL AB (publ) PUBLISHES INTERIM REPORT FOR THE PERIOD APRIL-JUNE 2023	AQ
24/08/23	RLS GLOBAL AB (PUBL) RAISES A SHORT-TERM LOAN OF MSEK 5.0	AQ
22/08/23	RLS Global appoints Torbjörn Sannerstedt as new Chief Financial Officer	AQ
01/06/23	RLS Global Q1 2023: Delay in Europe but progress in the Middle East	AQ
31/05/23	RLS Global AB (publ) Interim Report, Q1, 2023	AQ
20/03/23	ChloraSolv shows notably greater antibiofilm activity in vitro compared to other debridement products in published article	AQ
01/03/23	RLS Global Q4 2022 - No surprises – but expectations of an eventful 2023	AQ
28/02/23	RLS Global AB (publ) Year-end Report, Q4, 2022	AQ
24/01/23	Lars Johansson nominated as new Chairman of the Board of RLS Global AB	AQ
09/12/22	RLS Global: The rights issue is registered and the trading in Paid Subscription Shares ceases	AQ
24/11/22	RLS Global AB (publ) Interim Report, Q3, 2022	AQ
14/11/22	RLS Global: Outcome in RLS Global's rights issue	AQ
10/11/22	Presentation by Björn Larsson, CEO, RLS Global AB, about the company's operations and the currently ongoing rights issue	AQ
04/11/22	RLS Global's CEO Björn Larsson interviewed by Erik Penser Bank about the ongoing rights issue	AQ
25/10/22	RLS Global: RLS Global publishes prospectus	AQ
19/10/22	RLS Global: RLS Global resolves on a fully guaranteed rights issue of approximately SEK 29.4 million	AQ
23/09/22	RLS Global carries out an issue of shares by way of set-off, totalling approximately SEK 10	AQ
26/08/22	RLS GLOBAL AB (PUBL) INTERIM REPORT, Q2, 2022	AQ
23/08/22	Björn Larsson new CEO of RLS Global	AQ